Form 4: Rhythm Pharmaceuticals Corporate Controller Exercises Stock Options, Sells Shares to Cover Taxes

Christopher Paul German, Corporate Controller & CAO of Rhythm Pharmaceuticals, exercised restricted stock units and sold shares to cover withholding taxes on March 20 and 21, 2025.

Summary

• On March 20, 2025, Christopher Paul German, Corporate Controller & CAO of Rhythm Pharmaceuticals, exercised 1,163 restricted stock units, each representing a contingent right to receive one share of common stock.
• Following the exercise, Mr. German disposed of 1,163 shares.
• On March 21, 2025, Mr. German sold 344 shares of common stock at a price of $54.23 per share.
• The sale was executed pursuant to a pre-arranged non-Rule 10b5-1 trading plan to cover withholding taxes related to the vesting of restricted stock units.
• After these transactions, Mr. German directly owns 2,889 shares of Rhythm Pharmaceuticals common stock and 2,324 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.

Key Dates

Keywords

Rhythm Pharmaceuticals, RYTM, Christopher Paul German, Form 4, Restricted Stock Units, Stock Sale, Insider Trading, Corporate Controller, CAO, 10b5-1 trading plan